Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

TrimRx vs Willow

TrimRx costs $120 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
TrimRx logo

TrimRx

7.2
★★★★☆3.6/5

Best for: compounded semaglutide at $179/month

Visit TrimRx →
VS
Willow logo

Willow

6.6
★★★☆☆3.3/5

Best for: seeing what it charges before you answer any medical questions

Visit Willow →

If you are choosing between TrimRx and Willow, the first difference is cost: TrimRx is $120 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. TrimRx leads our six-part score, 7.2 to 6.6.

TrimRx vs Willow price

TrimRx is the cheaper way in: $179 a month against $299 a month at Willow. That is $120 less each month (40% lower), or about $1,440 over a year of treatment.

Drug by drug: Semaglutide is cheaper at TrimRx ($179 a month vs $299 a month); tirzepatide is cheaper at TrimRx ($259 a month vs $399 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, TrimRx prices compounded injections and brand-name pens, while Willow prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, TrimRx is the only one of the two with a brand-name price.

Where each one treats patients

Neither TrimRx nor Willow publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

TrimRx

Starting (flat across doses)Compounded
$179$135/mo
Save 25% right now
semaglutide

GLP-1 starts at $179. The homepage shows a $299.00 list price struck through to $179.00 for the first month, and an email sign-up offer promises '$120 OFF' your first order, for a first month as low as $135. Multi-month bundles (formerly $209/$191/$174) are no longer published; plan prices appear only after the intake questionnaire.

Starting (flat across doses)Compounded
$259/mo
tirzepatide

The GLP-1 + GIP plan, which contains tirzepatide, starts at $259, down from an earlier $279 limited offer. Multi-month bundles (formerly $316/$299/$283) are no longer published; plan prices appear only after the intake questionnaire.

StartingBrand-name
$1249/mo
tirzepatide (mounjaro)

'Mounjaro® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1249/mo
tirzepatide (zepbound)

'Zepbound® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1579/mo
semaglutide (wegovy)

'Wegovy® Starting at $1579' homepage tile; same branded-fulfillment caveat.

Willow

StartingCompounded
$299/mo
semaglutide
StartingCompounded
$399/mo
tirzepatide

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

TrimRx is silent on lab work and coaching.

Willow is silent on lab work and coaching.

TrimRx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Willow

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, TrimRx scores 7.2 and Willow 6.6 out of 10.

TrimRx is stronger on value (5.2 vs 3.0).

Effectiveness, user experience, trust & safety, accessibility and support are within half a point.

How we score

TrimRx

7.2/10

Overall

Willow

6.6/10

Value25%

5.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither TrimRx nor Willow has an FDA warning letter on record with us.

Features & Coverage

FeatureTrimRxWillow
Starting Price✓$179/mo$299/mo
Features✓8 features3 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About TrimRx

Three things TrimRx does not publish: the pharmacy that compounds its drugs, the states it serves, and any LegitScript certification. Specifics sit behind an intake quiz. What is visible is a cash-pay program with tiered monthly pricing plus multi-month bundles, no insurance, selling compounded semaglutide and tirzepatide shipped monthly at no shipping cost. Licensed US providers prescribe after reviewing an online medical history. The pitch is dose continuity and stable pricing: "switch and keep your current dose, no price hikes". Compounded GLP-1s are not FDA-approved.

Read our full TrimRx review →

About Willow

Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.

Read our full Willow review →

Pros & Cons

TrimRx

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $259 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to TrimRx

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Willow

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to Willow

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Willow

Willow is where we would start, above all for seeing what it charges before you answer any medical questions. TrimRx undercuts it by $120 a month, so if the monthly bill is what decides it, TrimRx is the pick. TrimRx fits better if compounded semaglutide at $179/month is your priority.

Choose TrimRx if…

You want compounded semaglutide at $179/month and an opening price near $179 a month.

Choose Willow if…

You want seeing what it charges before you answer any medical questions and an opening price near $299 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

TrimRx vs Willow: FAQ

TrimRx. It starts at $179 a month; Willow starts at $299 a month, $120 more per month.
Yes, both sell semaglutide and tirzepatide.
TrimRx does not publish where it ships; Willow does not publish where it ships. Confirm your state before paying.
Both include the clinician visit, the medication itself and shipping.
TrimRx has none. Willow has none.
Willow pays us a commission on sign-ups through our links; TrimRx does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.